These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38001858)
1. Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer. Bayanbold K; Singhania M; Fath MA; Searby CC; Stolwijk JM; Henrich JB; Pulliam CF; Schoenfeld JD; Mapuskar KA; Sho S; Caster JM; Allen BG; Buettner GR; Spies M; Goswami PC; Petronek MS; Spitz DR Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001858 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the iron chelator function of sirtinol in non-small cell lung cancer. Petronek MS; Bayanbold K; Amegble K; Tomanek-Chalkley AM; Allen BG; Spitz DR; Bailey CK Front Oncol; 2023; 13():1185715. PubMed ID: 37397370 [TBL] [Abstract][Full Text] [Related]
4. Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death. Liu WJ; Pan PY; Sun Y; Wang JB; Zhou H; Xie X; Duan ZY; Dong HY; Chen WN; Zhang LD; Wang C Front Oncol; 2021; 11():794735. PubMed ID: 35127502 [TBL] [Abstract][Full Text] [Related]
5. The cellular labile iron pool and intracellular ferritin in K562 cells. Konijn AM; Glickstein H; Vaisman B; Meyron-Holtz EG; Slotki IN; Cabantchik ZI Blood; 1999 Sep; 94(6):2128-34. PubMed ID: 10477743 [TBL] [Abstract][Full Text] [Related]
6. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status. Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313 [TBL] [Abstract][Full Text] [Related]
7. Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells. Jung IR; Choi SE; Jung JG; Lee SA; Han SJ; Kim HJ; Kim DJ; Lee KW; Kang Y Mol Cell Endocrinol; 2015 May; 407():74-84. PubMed ID: 25779532 [TBL] [Abstract][Full Text] [Related]
8. The labile iron pool: characterization, measurement, and participation in cellular processes(1). Kakhlon O; Cabantchik ZI Free Radic Biol Med; 2002 Oct; 33(8):1037-46. PubMed ID: 12374615 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo. Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621 [TBL] [Abstract][Full Text] [Related]
10. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Kurz T; Leake A; Von Zglinicki T; Brunk UT Biochem J; 2004 Mar; 378(Pt 3):1039-45. PubMed ID: 14670081 [TBL] [Abstract][Full Text] [Related]
11. Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxide. Al-Qenaei A; Yiakouvaki A; Reelfs O; Santambrogio P; Levi S; Hall ND; Tyrrell RM; Pourzand C Free Radic Biol Med; 2014 Mar; 68(100):87-100. PubMed ID: 24333634 [TBL] [Abstract][Full Text] [Related]
12. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. Yuan X; Cong Y; Hao J; Shan Y; Zhao Z; Wang S; Chen J J Mol Biol; 2004 May; 339(1):131-44. PubMed ID: 15123426 [TBL] [Abstract][Full Text] [Related]
13. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Richardson D; Ponka P; Baker E Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330 [TBL] [Abstract][Full Text] [Related]
14. Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice. Wang S; Liu C; Pan S; Miao Q; Xue J; Xun J; Zhang Y; Gao Y; Duan X; Fan Y Biochem Biophys Res Commun; 2015 Sep; 465(2):305-11. PubMed ID: 26277391 [TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle. Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725 [TBL] [Abstract][Full Text] [Related]
16. DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine. Yang SY; Li Y; An GS; Ni JH; Jia HT; Li SY Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843366 [TBL] [Abstract][Full Text] [Related]
17. Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest. Doulias PT; Christoforidis S; Brunk UT; Galaris D Free Radic Biol Med; 2003 Oct; 35(7):719-28. PubMed ID: 14583336 [TBL] [Abstract][Full Text] [Related]
18. Mustard Seed ( Ahmed AG; Hussein UK; Ahmed AE; Kim KM; Mahmoud HM; Hammouda O; Jang KY; Bishayee A Molecules; 2020 Apr; 25(9):. PubMed ID: 32365503 [TBL] [Abstract][Full Text] [Related]
19. Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair. Li XQ; Ren J; Chen P; Chen YJ; Wu M; Wu Y; Chen K; Li J Acta Pharmacol Sin; 2018 Aug; 39(8):1359-1372. PubMed ID: 29849128 [TBL] [Abstract][Full Text] [Related]
20. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth. Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]